These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

219 related articles for article (PubMed ID: 8033102)

  • 1. Fluorescence in situ hybridization analysis of 8p allelic loss and chromosome 8 instability in human prostate cancer.
    Macoska JA; Trybus TM; Sakr WA; Wolf MC; Benson PD; Powell IJ; Pontes JE
    Cancer Res; 1994 Jul; 54(14):3824-30. PubMed ID: 8033102
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Homozygous deletion and frequent allelic loss of chromosome 8p22 loci in human prostate cancer.
    Bova GS; Carter BS; Bussemakers MJ; Emi M; Fujiwara Y; Kyprianou N; Jacobs SC; Robinson JC; Epstein JI; Walsh PC
    Cancer Res; 1993 Sep; 53(17):3869-73. PubMed ID: 7689419
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinical significance of alterations of chromosome 8 detected by fluorescence in situ hybridization analysis in pathologic organ-confined prostate cancer.
    Tsuchiya N; Slezak JM; Lieber MM; Bergstralh EJ; Jenkins RB
    Genes Chromosomes Cancer; 2002 Aug; 34(4):363-71. PubMed ID: 12112525
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Deletion mapping of chromosome 8p in prostate cancer by fluorescence in situ hybridization.
    Matsuyama H; Pan Y; Skoog L; Tribukait B; Naito K; Ekman P; Lichter P; Bergerheim US
    Oncogene; 1994 Oct; 9(10):3071-6. PubMed ID: 8084616
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Interphase cytogenetics of prostatic tumor progression: specific chromosomal abnormalities are involved in metastasis to the bone.
    Alers JC; Krijtenburg PJ; Rosenberg C; Hop WC; Verkerk AM; Schröder FH; van der Kwast TH; Bosman FT; van Dekken H
    Lab Invest; 1997 Nov; 77(5):437-48. PubMed ID: 9389787
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Homozygous and frequent deletion of proximal 8p sequences in human prostate cancers: identification of a potential tumor suppressor gene site.
    Prasad MA; Trybus TM; Wojno KJ; Macoska JA
    Genes Chromosomes Cancer; 1998 Nov; 23(3):255-62. PubMed ID: 9790507
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A molecular cytogenetic analysis of 7q31 in prostate cancer.
    Jenkins RB; Qian J; Lee HK; Huang H; Hirasawa K; Bostwick DG; Proffitt J; Wilber K; Lieber MM; Liu W; Smith DI
    Cancer Res; 1998 Feb; 58(4):759-66. PubMed ID: 9485032
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Evidence for three tumor suppressor gene loci on chromosome 8p in human prostate cancer.
    Macoska JA; Trybus TM; Benson PD; Sakr WA; Grignon DJ; Wojno KD; Pietruk T; Powell IJ
    Cancer Res; 1995 Nov; 55(22):5390-5. PubMed ID: 7585607
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Decreased NKX3.1 protein expression in focal prostatic atrophy, prostatic intraepithelial neoplasia, and adenocarcinoma: association with gleason score and chromosome 8p deletion.
    Bethel CR; Faith D; Li X; Guan B; Hicks JL; Lan F; Jenkins RB; Bieberich CJ; De Marzo AM
    Cancer Res; 2006 Nov; 66(22):10683-90. PubMed ID: 17108105
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Fluorescence in situ hybridization evaluation of chromosome deletion patterns in prostate cancer.
    Huang SF; Xiao S; Renshaw AA; Loughlin KR; Hudson TJ; Fletcher JA
    Am J Pathol; 1996 Nov; 149(5):1565-73. PubMed ID: 8909246
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Analysis of 99 microdissected prostate carcinomas reveals a high frequency of allelic loss on chromosome 8p12-21.
    Vocke CD; Pozzatti RO; Bostwick DG; Florence CD; Jennings SB; Strup SE; Duray PH; Liotta LA; Emmert-Buck MR; Linehan WM
    Cancer Res; 1996 May; 56(10):2411-6. PubMed ID: 8625320
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Allelotyping analysis at chromosome arm 8p of high-grade prostatic intraepithelial neoplasia and incidental, latent, and clinical prostate cancers.
    Lu W; Takahashi H; Furusato B; Maekawa S; Ikegami M; Sudo A; Egawa S; Hano H
    Genes Chromosomes Cancer; 2006 May; 45(5):509-15. PubMed ID: 16470536
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Haploinsufficiency of 8p22 may influence cancer-specific survival in prostate cancer.
    Matsuyama H; Oba K; Matsuda K; Yoshihiro S; Tsukamoto M; Kinjo M; Sagiyama K; Takei M; Yamaguchi A; Sasaki K; Naito K
    Cancer Genet Cytogenet; 2007 Apr; 174(1):24-34. PubMed ID: 17350463
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Chromosome 8p deletions and 8q gains are associated with tumor progression and poor prognosis in prostate cancer.
    El Gammal AT; Brüchmann M; Zustin J; Isbarn H; Hellwinkel OJ; Köllermann J; Sauter G; Simon R; Wilczak W; Schwarz J; Bokemeyer C; Brümmendorf TH; Izbicki JR; Yekebas E; Fisch M; Huland H; Graefen M; Schlomm T
    Clin Cancer Res; 2010 Jan; 16(1):56-64. PubMed ID: 20028754
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Loss of p53 and c-myc overrepresentation in stage T(2-3)N(1-3)M(0) prostate cancer are potential markers for cancer progression.
    Qian J; Hirasawa K; Bostwick DG; Bergstralh EJ; Slezak JM; Anderl KL; Borell TJ; Lieber MM; Jenkins RB
    Mod Pathol; 2002 Jan; 15(1):35-44. PubMed ID: 11796839
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Allelic loss in locally metastatic, multisampled prostate cancer.
    Sakr WA; Macoska JA; Benson P; Grignon DJ; Wolman SR; Pontes JE; Crissman JD
    Cancer Res; 1994 Jun; 54(12):3273-7. PubMed ID: 7515768
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Distinct areas of allelic loss on chromosomal regions 10p and 10q in human prostate cancer.
    Trybus TM; Burgess AC; Wojno KJ; Glover TW; Macoska JA
    Cancer Res; 1996 May; 56(10):2263-7. PubMed ID: 8625295
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Deletions on chromosome 8p22 may predict disease progression as well as pathological staging in prostate cancer.
    Matsuyama H; Pan Y; Oba K; Yoshihiro S; Matsuda K; Hägarth L; Kudren D; Naito K; Bergerheim US; Ekman P
    Clin Cancer Res; 2001 Oct; 7(10):3139-43. PubMed ID: 11595707
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Sensitive detection of chromosome copy number aberrations in prostate cancer by fluorescence in situ hybridization.
    Visakorpi T; Hyytinen E; Kallioniemi A; Isola J; Kallioniemi OP
    Am J Pathol; 1994 Sep; 145(3):624-30. PubMed ID: 8080044
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The role of chromosome 8p22 deletion for predicting disease progression and pathological staging in prostate cancer.
    Matsuyama H; Pan Y; Oba K; Yoshihiro S; Matsuda K; Hägarth L; Kudren D; Naito K; Bergerheim US; Ekman P
    Aktuelle Urol; 2003 Jul; 34(4):247-9. PubMed ID: 14566675
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.